REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 14th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • California
This Registration Rights Agreement (“Agreement”) is entered into as of August 13, 2019 by and between AgeX Therapeutics, Inc., a California corporation (the “Company”) and the Juvenescence Limited, a company incorporated in the British Virgin Islands (“Holder”).
Warrant Agreement Dated as of August 13, 2019Warrant Agreement • August 14th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
WARRANT AGREEMENT, (this “Agreement”) dated as of August 12, 2019, by AgeX Therapeutics, Inc., a Delaware corporation (the “Company”), for the benefit of Juvenescence Limited which, along with any permitted successor Holder of a Warrant is referred to herein as a “Lender”.
DATED: August 13, 2019 AGEX THERAPEUTICS INC. (as Borrower) - and - JUVENESCENCE LIMITED (as Lender) LOAN FACILITY AGREEMENTLoan Facility Agreement • August 14th, 2019 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
The Lender has agreed to provide a nil interest unsecured loan facility to the Borrower in the aggregate principal amount of up to US$2,000,000 (two million dollars) on the terms and conditions set out in this Agreement.
